Simultaneously, CXCR4 expression showed a significant increase in OSCC patients with lymph node metastasis and a T3 tumor stage compared to those without lymph node metastasis and patients with T1–T2 stages [26,27,28,52]. This evidence concerns the gene CXCR4 and neoplasm.